Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Walpar Nutritions Ltd. Share Price
Day's Range
Day's Range
Low
₹0.00
High
₹0.00
Price Summary
| Previous Close | ₹36.50 |
|---|---|
| Day's Range | ₹0.00 - ₹0.00 |
| Open | ₹0.00 |
| 52 Week Range | ₹36.00 - ₹53.30 |
| Volume | 0 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 14.75 |
| TTM EPS (₹) | 2.48 |
| P/E Ratio | 17.09 |
| Book Value(₹) | 2.07 |
| PAT Margin (%) | 3.90 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 17.78 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 625.22 |
| Expenses | N/A | N/A |
| PBT | N/A | 24.94 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 19.46 |
About Walpar Nutritions Ltd.
| Founded | 2009 |
|---|---|
| Managing Director | Kalpesh Ladhawala |
| NSE Symbol | WALPAR |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,074.97 | 1,897.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,485.96 | 6,795.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,124.14 | 4,408.55 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,201.01 | 8,070.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,640.69 | 1,432.35 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,589.46 | 1,333.55 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,966.32 | 2,245.00 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,03,368.09 | 2,494.90 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,02,190.60 | 1,051.25 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,01,755.41 | 992.35 | 835.50 - 835.50 |
No Records Found
Latest News
Sandu Pharmaceuticals informs about compliance report
FDC informs about ANDA approval
Strides Pharma Science informs about update to earnings call
With reference to its intimation dated May 11, 2026, regarding the Earnings Call invite for investors and analysts to discuss the audited financial results of the Company for the quarter and financial year ended March 31, 2026, which is scheduled today, May 18, 2026. Strides Pharma Science has informed that US time for the said Earnings Call is 7:30 am EDT (instead of 6:30 am EST as communicated earlier). Updated timing for Earnings Call scheduled today is ‘5:00 PM IST/ 11:30 AM GMT/ 7:30 AM EDT/ 7:30 PM HKT’.
The above information is a part of company’s filings submitted to BSE.
Hester Biosciences informs about newspaper publication
Hester Biosciences informs about transcript of conference call
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that it attached the transcript of the earnings conference call held by the management of the Company with all investors on Friday, 15 May 2026 at 2:00 pm (IST) to discuss the financial results for the for the quarter and year ended 31 March 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Walpar Nutritions Ltd. is ₹36.50 as of 2026-05-18.
The market capitalisation of Walpar Nutritions Ltd. is ₹34.28 as of 2026-05-08.
The 1-year return of Walpar Nutritions Ltd. is 0.00% as of 2026-05-18.
The P/E ratio of Walpar Nutritions Ltd. is 17.09 as of 2026-05-18.
The 52-week high and low of Walpar Nutritions Ltd. are ₹53.30 and ₹36.00, respectively, as of 2026-05-18.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
